A three-way crossover clinical pharmacological study to evaluate a drug interaction on P-gp at blood brain barrier between histamine H1 receptor antagonist ebastine and P-gp inhibitor verapamil by using saccadic eye movement analyzing system and visual analogue scale (VAS) in healthy Japanese male volunteers
Phase of Trial: Phase I
Latest Information Update: 27 Apr 2007
At a glance
- Drugs Ebastine (Primary) ; Verapamil
- Indications Allergic rhinitis; Angina pectoris; Arrhythmias; Hypertension; Urticaria
- Focus Pharmacodynamics
- 27 Apr 2007 Status changed from suspended to completed.
- 07 Feb 2007 New trial record.